VACC
Income statement / Annual
Last year (2024), Vaccitech plc's total revenue was $14.97 M,
a decrease of 66.51% from the previous year.
In 2024, Vaccitech plc's net income was -$61.07 M.
See Vaccitech plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$14.97 M |
$44.70 M |
$268.00 K |
$4.82 M |
$6.85 M |
| Cost of Revenue |
$0.00
|
$42.35 M
|
$20.37 M
|
$14.39 M
|
$29.84 M
|
| Gross Profit |
$0.00
|
$2.35 M
|
-$20.10 M
|
-$9.57 M
|
-$23.00 M
|
| Gross Profit Ratio |
0
|
0.05
|
-75.01
|
-1.98
|
-3.36
|
| Research and Development Expenses |
$42.24 M
|
$41.11 M
|
$16.37 M
|
$11.11 M
|
$29.84 M
|
| General & Administrative Expenses |
$29.67 M
|
$6.39 M
|
$25.12 M
|
$10.48 M
|
$2.67 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$29.67 M
|
$6.39 M
|
$25.12 M
|
$10.48 M
|
$2.67 M
|
| Other Expenses |
$12.21 M
|
$567.00 K
|
$332.00 K
|
$41.69 K
|
$0.00
|
| Operating Expenses |
$84.12 M
|
$47.50 M
|
$41.49 M
|
$21.59 M
|
$391.96 K
|
| Cost And Expenses |
$0.00
|
$47.50 M
|
$41.49 M
|
$21.59 M
|
$30.23 M
|
| Interest Income |
$2.68 M
|
$3.10 M
|
$2.00 K
|
$265.00
|
$92.55 K
|
| Interest Expense |
-$53.00 K
|
$19.00 K
|
$2.67 M
|
$3.60 M
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$4.32 M
|
$4.34 M
|
$3.53 M
|
$345.43 K
|
| EBITDA |
$1.18 M |
$869.00 K |
-$45.22 M |
-$16.52 M |
-$22.52 M |
| EBITDA Ratio |
0.08
|
0.02
|
-168.74
|
-3.43
|
-3.29
|
| Operating Income Ratio |
0.08
|
-0.08
|
-168.74
|
-4.16
|
-3.31
|
| Total Other Income/Expenses Net |
-$62.40 M
|
$4.89 M
|
-$5.92 M
|
$2.21 M
|
-$9.10 K
|
| Income Before Tax |
-$61.23 M
|
$850.00 K
|
-$51.14 M
|
-$17.84 M
|
-$22.70 M
|
| Income Before Tax Ratio |
-4.09
|
0.02
|
-190.82
|
-3.7
|
-3.32
|
| Income Tax Expense |
-$153.00 K
|
-$4.47 M
|
-$28.00 K
|
$95.01 K
|
-$1.97 M
|
| Net Income |
-$61.07 M
|
$5.34 M
|
-$51.11 M
|
-$17.93 M
|
-$20.73 M
|
| Net Income Ratio |
-4.08
|
0.12
|
-190.72
|
-3.72
|
-3.03
|
| EPS |
-1.55 |
0.14 |
-1.97 |
-2.27 |
-883.28 |
| EPS Diluted |
-1.55 |
0.14 |
-1.97 |
-2.27 |
-883.28 |
| Weighted Average Shares Out |
$39.35 M
|
$37.25 M
|
$25.89 M
|
$7.90 M
|
$23.47 K
|
| Weighted Average Shares Out Diluted |
$39.35 M
|
$38.17 M
|
$25.89 M
|
$7.90 M
|
$23.47 K
|
| Link |
|
|
|
|
|
